Aehr Test Systems Surges 11.6% as It Targets Double‑Digit Revenue Growth for 2027

Aehr Test Systems (NASDAQ:AEHR) shares jumped 11.6% week‑on‑week after management unveiled an aggressive outlook targeting a near‑tripling of revenue by fiscal 2027.

Triple‑Revenue Target: A Bold 2027 Playbook

The company aims for a 160‑200% revenue increase, projecting $130‑150 million for fiscal 2027 versus $50 million posted last year.

Q4 Results Defy Expectations

■Net income: $1.4 million, a swing from a ‑$2.9 million loss in the same quarter last year.

■Revenue surged 33% to $18.8 million year‑on‑year.

■Record bookings of $60.7 million; backlog closed at $80.6 million.

Institutional Appetite: Hedge Funds Pile In

■25 hedge funds held positions in AEHR at the end of Q1, up from 17 the prior quarter.

■Collective stake totals roughly $60.9 million.

Risk‑Reward Landscape

■Full‑year 2026 net loss widened 82% to $7.1 million, driven by early‑year deficits despite a strong Q4 rebound.

■Growing demand for AI processors, silicon photonics, and power semiconductors underpins the company’s wafer‑level and package‑level burn‑in solutions.

The market views AEHR's robust backlog and AI‑driven demand as a credible catalyst for its 2027 growth narrative. Nonetheless, the sizable 2026 losses warrant close monitoring of cash flow and margin pressures. A softening global chip supply crunch and sustained demand for semiconductor testing services remain the key tailwinds supporting the stock’s upside potential.